We are live on ! Find out more
BFRIW icon

Biofrontera

2 hedge funds and large institutions have $396K invested in Biofrontera in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

2.34% more ownership

Funds ownership: 0%2.34% (+2.3%)

60% less funds holding

Funds holding: 52 (-3)

64% less capital invested

Capital invested by funds: $1.11M → $396K (-$712K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-3
Holders Change %
-60%
% of All Funds
0.03%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
1
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
BA
1
Bard Associates
Illinois
$286K -$19.6K -14,100 -7%
EAM
2
Empery Asset Management
New York
$110K
WAM
3
Warberg Asset Management
Illinois
-$67K -18,487 Closed
UBS Group
4
UBS Group
Switzerland
-$10K -2,750 Closed
FDCDDQ
5
Federation des caisses Desjardins du Quebec
Quebec, Canada
-$4.5K -1,250 Closed

BFRIW Hedge Fund Activity: Q1 2022 in Review

2 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Biofrontera (BFRIW) for Q1 2022, worth a combined $396K — down 64% from $1.11M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of BFRIW and 0 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Warberg Asset Management, exiting entirely with an estimated $67K sold.

  • 2 institutional investors held Biofrontera (BFRIW) as of Q1 2022, down from 5 in Q4 2021.
  • Funds reported $396K of Biofrontera stock for Q1 2022, down 64% quarter-over-quarter.
  • 0 funds opened new Biofrontera positions in Q1 2022 and 3 closed out, a net change of -3 holders.
  • The largest Biofrontera seller in Q1 2022 was Warberg Asset Management, an estimated $67K sold.

Based on aggregated 13F filings for Q1 2022.